These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30597863)

  • 41. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of HDACs in cardiac electropathology: Therapeutic implications for atrial fibrillation.
    Brundel BJJM; Li J; Zhang D
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118459. PubMed ID: 30880147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein acetylation in cardiac aging.
    Francois A; Canella A; Marcho LM; Stratton MS
    J Mol Cell Cardiol; 2021 Aug; 157():90-97. PubMed ID: 33915138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance.
    Bahl S; Seto E
    Cell Mol Life Sci; 2021 Jan; 78(2):427-445. PubMed ID: 32683534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
    Li P; Ge J; Li H
    Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation.
    Leus NG; Zwinderman MR; Dekker FJ
    Curr Opin Chem Biol; 2016 Aug; 33():160-8. PubMed ID: 27371876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure.
    Lkhagva B; Lin YK; Kao YH; Chazo TF; Chung CC; Chen SA; Chen YJ
    Pharmacology; 2015; 96(3-4):184-91. PubMed ID: 26304494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism.
    Blakeslee WW; Wysoczynski CL; Fritz KS; Nyborg JK; Churchill ME; McKinsey TA
    Cell Signal; 2014 Dec; 26(12):2912-20. PubMed ID: 25220405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation.
    Hesping E; Skinner-Adams TS; Fisher GM; Kurz T; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():249-256. PubMed ID: 33279862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDAC Inhibitors.
    Olzscha H; Bekheet ME; Sheikh S; La Thangue NB
    Methods Mol Biol; 2016; 1436():281-303. PubMed ID: 27246222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
    Weeks KL; Avkiran M
    J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of histone deacetylases in bone development and skeletal disorders.
    Wang JS; Yoon SH; Wein MN
    Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.
    Joanna F; van Grunsven LA; Mathieu V; Sarah S; Sarah D; Karin V; Tamara V; Vera R
    J Cell Mol Med; 2009 Sep; 13(9B):2990-3005. PubMed ID: 19583816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis.
    Vong P; Ouled-Haddou H; Garçon L
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
    Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
    Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A translational perspective on histone acetylation modulators in psychiatric disorders.
    Ganguly S; Seth S
    Psychopharmacology (Berl); 2018 Jul; 235(7):1867-1873. PubMed ID: 29915963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.